Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2003 | 08-2002 | 08-2001 | 08-2000 | 08-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90 | -200 | -360 | -300 | -360 |
| Depreciation Amortization | 30 | 30 | 30 | 30 | 50 |
| Other Working Capital | -10 | -20 | 30 | -10 | -5 |
| Other Operating Activity | 0 | 0 | 10 | 0 | 5 |
| Operating Cash Flow | $-70 | $-190 | $-290 | $-280 | $-310 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | 0 | 0 | -9 | -5 |
| Other Investing Activity | -3 | 130 | 350 | -171 | 65 |
| Investing Cash Flow | $-5 | $130 | $350 | $-180 | $60 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 60 | 70 | 380 | 50 |
| Financing Cash Flow | $0 | $60 | $70 | $380 | $50 |
| Beginning Cash Position | 200 | 190 | 60 | 150 | 350 |
| End Cash Position | 110 | 200 | 190 | 60 | 150 |
| Net Cash Flow | $-80 | $4 | $130 | $-80 | $-190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70 | -190 | -290 | -280 | -310 |
| Free Cash Flow | -70 | -190 | -290 | -280 | -310 |